Login / Signup

Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.

Christian GrossManuel WeberKay CreutzburgPatrick MöbiusRaimund PreidlKerstin AmannFalk Wehrhan
Published in: Journal of translational medicine (2017)
This study indicates that the osteoclast profile of MRONJ (BP) is characterized by osteoclast inactivation and a high cell-cell fusion rate; however, the presence of giant, hypernucleated osteoclasts cannot be attributed to increased DC-STAMP-triggered cell-cell fusion alone. The incidental characterization of the osteoclast profiles of OM and ORN revealed differences that might facilitate the histopathological differentiation of these diseases from MRONJ (BP), which is essential because their therapies are somewhat different.
Keyphrases
  • single cell
  • cell therapy
  • bone loss
  • stem cells
  • emergency department
  • immune response
  • mesenchymal stem cells
  • adverse drug
  • replacement therapy
  • drug induced